Title: The New Millennium: Values, Perceptions of Risk and the Key Roles of Science and Technology
1The New Millennium Values, Perceptions of Risk
and the Key Roles of Science and Technology
- Ionizing Radiation Science and Protection In the
21st Century - Gilbert S. Omenn, MD, PhD
- Executive Vice President for Medical Affairs and
CEO, University of Michigan Health System - National Council on Radiation Protection and
Measurements - April 5-6, 2000 Arlington, Virginia
2AMERICAN VALUES FOR THIS MILLENNIUM
- Sustainable development Robust economy,
- environmental protection, inter-dependent
world - Freedom of speech, freedom of religion,
freedom from - want, freedom from fear (FDR, 1941)
- Transparency of decision-making in an
internet- - informed or misinformed, more empowered
populace - High expectations and benefits and tolerance
for risks - from science and technology
3SOURCES OF IONIZING RADIATION EXPOSURES
- Nature background radon progeny
- Medical Diagnostic and Therapeutic Uses
- Industrial Radionuclides
- Radioactive Liquid and Solid Wastes
- Nuclear Power Plant Operations / Emissions Risk
- Decommissioning of Nuclear Reactors
4- I know no safe depository of the ultimate powers
of society but the people themselves if we think
them not enlightened enough to exercise their
control with a wholesome discretion, the remedy
is not to take it away from them, but to inform
their discretion. - - Thomas Jefferson
5RISK PERCEPTION
- NOT OBSERVABLE
- Unknown to those exposed
- Effect delayed
- New risk
- Risks unknown to science
- OBSERVABLE
- Known to those exposed
- Effect immediate
- Old risk
- Risks known to science
6- CONTROLLABLE
- Not dread
- Not catastrophic
- Not fatal
- Equitable
- Low risk to future generations
- Easily reduced
- Risk decreasing
- Voluntary
- UNCONTROLLABLE
- Dread
- Global catastrophic
- Consequences fatal
- Not equitable
- High risk to future generations
- Not easily reduced
- Risk increasing
- Involuntary
7FRAMEWORK FOR REGULATORY DECISION-MAKING
- Epidemiology
- Hazard Identification Lifetime rodent
bioassays - Short-term, in vitro tests
- Structure / activity
- Potency (dose/response)
- Risk Characterization Exposure analysis
- Variation in susceptibility
- Information
- Risk Reduction Substitution
- Regulation / Prohibition
-
8Objectives of Risk Assessment
- 1. Balance risks and benefits
- Drugs
- Pesticides
- 2. Set target levels of risk
- Food contaminants
- Water Pollutants
- 3. Set priorities for program activities
- Regulatory agencies
- Manufacturers
- Environmental/Consumer organizations
- 4. Estimate residual risks and extent of risk
- Reduction after steps are taken to reduce risks
9(No Transcript)
10BIOLOGICAL END-POINTS
- Cancers
- Mutations
- Birth Defects
- Reproductive Toxicity
- Immunological Toxicity
- Neurobehavioral Toxicity
- Organ-Specific Effects
- Endocrine Modulation/Disruption
- Ecosystem Effects
11Major Toxic Chemical Laws
- EPA Air pollutants Clean Air Act
1970, 1977, 1990 - Water Pollutants Fed
WP Control Act 1972, 1977 - Safe Drinking Water
Safe DW Act 1974 - Pesticides
FIFRA 1972 - Ocean Dumping
Marine Protection Act - Toxic Chemicals
TSCA 1976 - Hazardous Wastes RCRA
1976 - Hazardous Waste Cleanup CERCLA
(Sperfund) 1980, 1986 - CEQ Envvlt Impacts NEPA
- OSHA Workplace OSH
Act - FDA Foods, Drugs, Cosmetics FDC Acts
- CPSC Dangerous Consumer Products CPS Act
- DOT Transport of Haz Materials THM
Act
12MANDATE
- Uses and limitation of risk assessment
- in decision-making
- Appropriate exposure scenarios
- Uncertainty and risk communication
- Risk management policy issues
- Consistency across agencies
13(No Transcript)
14EXPOSURE
- Sources
- Pathways
- Environmental transformations
- Routes of entry
- Time course of exposures
- Concept of total exposure
- Need for translation from ambient levels to
target tissue effective dose - New methods for tissue burdens and dosimetry
15MIXTURES
- Test real world mixtures
- diesel exhaust
- urban smog
- actual effluents
- pesticide combinations
- workplaces
- Assume additivity of risks as default use
mechanisms, if known - Pay attention to radiation and microbial
exposures/risks
16PUTTING ENVIRONMENTAL RISKS INTO CONTEXT
- Multi-Source
- Multi-Media
- Multi-Chemical / Multi-Agent
- Multi-Risk
17CONTEXT
- Multi-Source
- Multi-Media
- Multi-Agent
- Multi-Risk
- Public Health
- Status/Trends
- Ecological Health
- Social Cultural
- Environmental Justice Considerations
18Reducing risk by orders of magnitude is not
equivalent to linear reductions
Risk Commission, Final Report, 1997
19RISK COMMISSION RECOMMENDATION (1997 REPORT, p.
82)
- A concerted effort should be made to evaluate and
relate the methods, assumptions, mechanisms, and
standards for radiation risks to those for
chemicals to clarify and enhance the
comparability of risk management decisions,
especially when both types of hazards are present.
20- LACK OF COLLABORATION ON CHEMICAL AND RADIATION
- HAZARDS
- Different models of carcinogenesis
- Different regulatory laws and agencies
- Different disciplines and scientific meetings
- Smaller margin of exposure tolerated for IR
- Despite common waste streams and co-existing
contamination
21POLICY AND PUBLIC INTEREST IN COMPARISONS OF RISK
- Discrepancy between levels of risk considered
negligible for - radiation exposures and for chemical exposures
- Workers General
Population Comments - Chemicals 10-3 10-6
Single chemicals - Radiation 50 mSV/yr 1mSV/yr
Integrated - Dose
- 10-1 / 10-2 Ratio of 50
-
vs 300 - Importance of interactions of radiation and
chemicals, of - radiation and infectious disease risks.
22BEIR VII - Phase 1 Letter---21 January, 1998
- Continued reliance on epidemiological studies
- Lots of laboratory studies
- OPPORTUNITY FOR REALLY BIG BREAKTHROUGH
- - Patterns of gene expression on microarray
- and protein expression in proteomics
- readouts that reflect carcinogenesis key
to - resolving long-festering questions about
risks of - low-level exposures
23OUR GENETIC FUTURE
- Mapping the human genetic terrain may rank with
the great expeditions of Lewis and Clark, Sir
Edmund Hillary, and the Apollo Program. - --Francis Collins, Director
- National Human Genome Research Institute, 1999